HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marijke Stigter-van Walsum Selected Research

Radioisotopes (Radionuclides)

11/2005(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marijke Stigter-van Walsum Research Topics

Disease

24Neoplasms (Cancer)
10/2023 - 03/2003
7Head and Neck Neoplasms (Head and Neck Cancer)
10/2023 - 08/2003
7Squamous Cell Carcinoma of Head and Neck
10/2023 - 03/2003
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2015 - 04/2013
2Lung Neoplasms (Lung Cancer)
01/2015 - 10/2014
1Glioblastoma (Glioblastoma Multiforme)
04/2012
1Neoplasm Metastasis (Metastasis)
10/2008
1Stomach Neoplasms (Stomach Cancer)
10/2008
1Residual Neoplasm
10/2007
1Acquired Immunodeficiency Syndrome (AIDS)
10/2007
1Leukemia
10/2007

Drug/Important Bio-Agent (IBA)

5Cetuximab (Erbitux)FDA Link
10/2021 - 11/2005
4ErbB Receptors (EGF Receptor)IBA
01/2015 - 07/2006
4Monoclonal AntibodiesIBA
10/2014 - 08/2003
3Single-Domain AntibodiesIBA
10/2013 - 08/2008
2Immunoconjugates (Immunoconjugate)IBA
10/2023 - 08/2003
2Proteins (Proteins, Gene)FDA Link
10/2023 - 02/2012
2RNA (Ribonucleic Acid)IBA
06/2019 - 10/2013
2Small Interfering RNA (siRNA)IBA
06/2015 - 04/2013
2AfatinibIBA
01/2015 - 10/2014
2Tyrosine Kinase InhibitorsIBA
01/2015 - 05/2013
2Chemokine ReceptorsIBA
10/2013 - 04/2009
2AntigensIBA
10/2007 - 03/2003
2(124)I-cMAb U36IBA
08/2003 - 08/2003
1monomethyl auristatin EIBA
10/2023
1tisotumab vedotinIBA
10/2023
1Thromboplastin (Tissue Factor)IBA
10/2023
1LigandsIBA
10/2021
1Neoplasm Antigens (Tumor Antigens)IBA
10/2021
1Toll-Like Receptor 2IBA
10/2021
1Checkpoint Kinase 1IBA
06/2019
1MicroRNAs (MicroRNA)IBA
06/2019
1adavosertibIBA
06/2019
1LY2603618IBA
06/2019
1Polo-Like Kinase 1IBA
11/2017
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2015
1tariquidar (XR9576)IBA
01/2015
1Glycoproteins (Glycoprotein)IBA
01/2015
1TUB-OMOM-trastuzumabIBA
10/2014
1Ado-Trastuzumab EmtansineIBA
10/2014
1Trastuzumab (Herceptin)FDA Link
10/2014
1Fluorine-18IBA
10/2014
1Peptides (Polypeptides)IBA
10/2014
1Indicators and Reagents (Reagents)IBA
10/2014
1RG7356IBA
03/2014
1Chemokine CXCL1IBA
10/2013
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2013
1Sorafenib (BAY 43-9006)FDA Link
05/2013
1Antineoplastic Agents (Antineoplastics)IBA
04/2013
1ispinesibIBA
04/2013
1Zirconium-89IBA
04/2012
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2012
1Coloring Agents (Dyes)IBA
12/2011
1Fluorescent Dyes (Fluorescent Probes)IBA
12/2011
1AzidesIBA
10/2011
1phosphine (phosphane)IBA
10/2011
1Trichlormethiazide (Naqua)FDA Link
10/2011
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2009
1Celecoxib (Celebrex)FDA Link
04/2009
1IodineIBA
10/2008
1AlbuminsIBA
08/2008
1Fibronectins (Fibronectin)IBA
07/2006
1Radioisotopes (Radionuclides)IBA
11/2005
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
08/2003

Therapy/Procedure

6Therapeutics
10/2021 - 03/2003
3Drug Therapy (Chemotherapy)
10/2023 - 10/2007
3Radiotherapy
10/2023 - 05/2013
3Radioimmunotherapy
07/2006 - 08/2003
1Chemoradiotherapy
10/2023
1Immunotherapy
10/2021
1Ligation
10/2011